Evidence map›Paper›PMID 40427052›Full record

ArticleBiomedicines2025

Inhibition of TPI1 Sensitizes Cisplatin-Resistant Oral Cancer to Ferroptosis.

Dandan Wang, Huimin Zheng, Yumin Chen, Jialin Hao, Yuan Zhou, Nan Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer.International journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dandan WangDepartment of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Huimin ZhengDepartment of Geriatric Dentistry, Beijing Laboratory of Biomedical Materials, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Yumin ChenDepartment of Geriatric Dentistry, Beijing Laboratory of Biomedical Materials, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Jialin HaoDepartment of Prosthodontics, Stomatological Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai 200072, China.
Yuan ZhouShenzhen Stomatological Hospital, Southern Medical University, 1092 Jianshe Road, Luohu District, Shenzhen 518001, China.
Nan LiDepartment of Stomatology, Shenzhen People's Hospital, Shenzhen 518020, China.

Funding

Educational Commission of Guangdong Province No.2022KTSCX019)Medical Scientific Research Foundation of Guangdong Province No. A2023118Natural Science Foundation of China, Youth Project No.82401182, No.32000516SanmingProject of Medicine in Shenzhen No.SZSM202311009Scientific Research Project of Administration of Traditional Chinese Medicine of Guangdong Province No. 20221272Shenzhen science and technology research and development fund No.JCYJ20190809165805604
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cisplatin-resistantferroptosisoral cancerTPI1

Identifiers

PMID40427052
PMCPMC12108594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.